Imunon, Inc. (IMNN)
NASDAQ: IMNN · Real-Time Price · USD
3.900
-0.100 (-2.50%)
At close: Dec 5, 2025, 4:00 PM EST
3.880
-0.020 (-0.51%)
After-hours: Dec 5, 2025, 6:05 PM EST
Imunon Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Revenue | - | - | - | 0.5 | 0.5 | 0.5 | |
| Cost of Revenue | - | - | - | - | 10.62 | 11.34 | |
| Gross Profit | - | - | - | 0.5 | -10.12 | -10.84 | |
| Selling, General & Admin | 7.01 | 7.49 | 9.74 | 13.69 | 10.89 | 7.64 | |
| Research & Development | 7.52 | 11.64 | 11.29 | 11.73 | - | - | |
| Operating Expenses | 14.54 | 19.13 | 21.03 | 25.42 | 10.89 | 7.64 | |
| Operating Income | -14.54 | -19.13 | -21.03 | -24.92 | -21.01 | -18.49 | |
| Interest Expense | - | - | -0.2 | -5.03 | -0.57 | -1.29 | |
| Interest & Investment Income | 0.21 | 0.51 | 1.16 | 0.45 | 0.01 | 0.12 | |
| Other Non Operating Income (Expenses) | - | - | -0.4 | 0 | 0 | 0 | |
| EBT Excluding Unusual Items | -14.33 | -18.62 | -20.47 | -29.5 | -21.56 | -19.66 | |
| Impairment of Goodwill | - | - | - | - | -1.98 | - | |
| Other Unusual Items | - | - | -0.33 | 5.4 | 1.39 | -1.3 | |
| Pretax Income | -14.33 | -18.62 | -20.8 | -37.47 | -22.15 | -23.33 | |
| Income Tax Expense | - | - | -1.28 | -1.57 | -1.38 | -1.85 | |
| Net Income | -14.33 | -18.62 | -19.51 | -35.9 | -20.77 | -21.48 | |
| Net Income to Common | -14.33 | -18.62 | -19.51 | -35.9 | -20.77 | -21.48 | |
| Shares Outstanding (Basic) | 2 | 1 | 1 | 1 | 0 | 0 | |
| Shares Outstanding (Diluted) | 2 | 1 | 1 | 1 | 0 | 0 | |
| Shares Change (YoY) | 57.50% | 27.23% | 26.63% | 31.62% | 154.70% | 46.39% | |
| EPS (Basic) | -9.54 | -21.10 | -28.14 | -65.55 | -49.92 | -131.51 | |
| EPS (Diluted) | -9.54 | -21.10 | -28.14 | -65.55 | -49.92 | -131.51 | |
| Free Cash Flow | -14.95 | -18.88 | -19.47 | -23.36 | -16.54 | -15.64 | |
| Free Cash Flow Per Share | -9.96 | -21.40 | -28.08 | -42.66 | -39.74 | -95.73 | |
| Gross Margin | - | - | - | 100.00% | - | - | |
| Operating Margin | - | - | - | -4984.31% | -4201.44% | -3697.28% | |
| Profit Margin | - | - | - | -7179.65% | -4153.85% | -4296.71% | |
| Free Cash Flow Margin | - | - | - | -4672.94% | -3307.04% | -3127.55% | |
| EBITDA | -14.28 | -18.89 | -20.78 | -24.73 | -20.3 | -17.74 | |
| D&A For EBITDA | 0.25 | 0.24 | 0.25 | 0.2 | 0.7 | 0.74 | |
| EBIT | -14.54 | -19.13 | -21.03 | -24.92 | -21.01 | -18.49 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.